ID   KPC-32
AC   CVCL_M532
DR   Wikidata; Q54900429
RX   CelloPub=CLPUB00068;
RX   PubMed=8080996;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
RX   CelloPub=CLPUB00068;
RA   Goto T., Takishita M., Wada M., Tsuchihashi N., Miyamoto Y., Jo Z.,
RA   Okagawa K., Kosaka M., Saito S.;
RT   "Establishment of a human myeloma cell line (KPC-32) and production of
RT   monoclonal antibodies to its surface antigen.";
RL   Jpn. J. Clin. Hematol. 32:1400-1400(1991).
//
RX   PubMed=8080996; DOI=10.1182/blood.V84.6.1922.1922;
RA   Goto T., Kennel S.J., Abe M., Takishita M., Kosaka M., Solomon A.,
RA   Saito S.;
RT   "A novel membrane antigen selectively expressed on terminally
RT   differentiated human B cells.";
RL   Blood 84:1922-1930(1994).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//